鞍区混合性神经节细胞瘤-垂体腺瘤:大规模单中心经验
回顾性分析20例鞍区混合性神经节细胞瘤-垂体腺瘤患者的临床、影像和病理资料,所有患者均经内镜或显微镜经蝶入路手术切除。平均随访42.5±29.0个月,无复发。作者认为经蝶手术是首选治疗且预后良好,病理发现更支持腺瘤细胞神经元转分化起源学说。
要点
- 鞍区混合性神经节细胞瘤-垂体腺瘤临床和影像学特征无特异性,海绵窦侵犯常见。
- 经蝶入路手术切除是首选治疗,本组15例全切、5例次全切,平均随访42.5±29.0个月无复发。
- 病理发现更支持肿瘤起源于腺瘤细胞的神经元转分化。
核心结论
- 鞍区混合性神经节细胞瘤-垂体腺瘤的临床和神经影像特征无特异性,海绵窦侵犯常见。
- 经蝶入路手术切除是首选治疗,手术结局良好。
- 作者的组织病理学发现更支持混合性神经节细胞瘤-垂体腺瘤起源于腺瘤细胞的神经元转分化这一理论。
研究设计与样本
- 回顾性分析单中心20例鞍区混合性神经节细胞瘤-垂体腺瘤患者的临床、影像和病理资料。
- 所有患者均经内镜或显微镜经蝶入路行手术肿瘤切除。
- 回顾围手术期磁共振成像(MRI)和计算机断层扫描(CT)数据,并进行免疫组化染色和电子显微镜检查,随访结局。
主要发现
- 本组包括13例女性和7例男性,年龄范围20-59岁,平均年龄42.3±11.2岁。
- 术前内分泌检查显示9例生长激素(GH)升高,8例高泌乳素血症。
- 肿瘤免疫组化阳性:GH 15例,泌乳素13例,促肾上腺皮质激素3例,促甲状腺激素1例。
- 全切除15例,次全切除5例。
- 平均随访42.5±29.0个月期间未见复发。
临床怎么用
- 作者认为经蝶入路手术切除是首选治疗,手术结局良好。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mixed gangliocytoma-pituitary adenoma is an extremely rare tumor occurring in the sellar region, histologically composed of both gangliocytic and pituitary adenomatous architectures. The histogenesis of these tumors remains unknown, and the diagnosis, treatment, and prognosis are yet to be fully understood. METHODS: We retrospectively reviewed the clinical, radiological, and histopathological profiles from a series of 20 patients with sellar mixed gangliocytoma-pituitary adenomas. All patients underwent surgical tumorectomy via an endoscopic or microscopic transsphenoidal approach. Perioperative magnetic resonance imaging (MRI) and computed tomography (CT) data were reviewed. Immunohistochemical stains and electron microscopy examination were performed. Follow-up outcomes were presented. RESULTS: This case series consisted of 13 females and seven males (age range, 20-59 years; mean age, 42.3 ± 11.2 years). Preoperative endocrine examination showed elevated growth hormone (GH) in nine patients and hyperprolactinemia in eight patients. The tumors were positive for GH in 15 cases, prolactin in 13 cases, adrenocorticotropic hormone in three cases, and thyroid-stimulating hormone in one case. Gross total resection was achieved in 15 patients, and subtotal resection in five patients. During an average follow-up period of 42.5 ± 29.0 months, no recurrence was noted. CONCLUSIONS: The clinical and neuroimaging features of sellar mixed gangliocytoma-pituitary adenomas are non-specific, and invasion into the cavernous sinus is common. Surgical resection via a transsphenoidal approach is the preferred treatment, and the surgical outcomes are favorable. Moreover, our histopathological findings are more likely to support the theory that mixed gangliocytoma-pituitary adenoma originates from the neuronal transdifferentiation of adenomatous cells.
引用
- Yang B, Yang C, Sun Y, et al. Mixed gangliocytoma-pituitary adenoma in the sellar region: a large-scale single-center experience. Acta Neurochir (Wien). 2018. PMID: 30109498. doi:10.1007/s00701-018-3632-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。